Quarterly ResultAug 6, 2026, 04:40 PM
RXO Q2 Revenue $1.77B; Net Loss $(9)M; Refinances Debt
AI Summary
RXO reported Q2 2026 revenue of $1.77 billion, a 25.0% increase year-over-year, while net loss remained flat at $(9) million. For the first half of 2026, revenue grew to $3.20 billion, but net loss widened to $(45) million. The company completed a significant debt refinancing, entering into a new ABL Facility and issuing $400 million in 6.375% Notes due 2031, which allowed for the redemption of its 7.50% Notes due 2027. RXO also incurred $14 million in restructuring charges and settled two legal misclassification claims for immaterial amounts.
Key Highlights
- Entered ABL Facility with $450 million commitment; $335 million available as of June 30, 2026.
- Issued $400 million in 6.375% Notes due 2031 and redeemed 7.50% Notes due 2027.
- Q2 2026 revenue increased 25.0% year-over-year to $1.77 billion.
- Q2 2026 net loss was $(9) million, flat compared to the prior year.
- H1 2026 net loss widened to $(45) million from $(40) million year-over-year.
- Segment adjusted EBITDA for Q2 2026 was $51 million, a 1.9% decrease year-over-year.
- Incurred $14 million in restructuring charges during H1 2026.
- Settled two legal misclassification claims for immaterial amounts.
Price Impact
More from RXO